Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Heba Gadelkareem

Heba Gadelkareem

Institutions of which they are part

Research assistant
Liver Diseases
Vall Hebron Institut de Recerca
Heba Gadelkareem

Heba Gadelkareem

Heba Gadelkareem

Institutions of which they are part

Research assistant
Liver Diseases
Vall Hebron Institut de Recerca

Related news

Dr. Raul Herance

We develop a method to diagnose fatty liver in a quantitative and non-invasive way

Using computed tomography (CT), with or without contrast, it is possible to perform an accurate and safe detection of the disease without the need for biopsies and avoiding the limitations of other non-invasive diagnostic tools.

Pacient d'un assaig clínic a la consulta

VHIR exceeds 700 active clinical trials to achieve new therapies for patients

On World Clinical Trials Day, we highlight some of the studies we have participated in that confirm the efficacy of new drugs, allowing their approval by regulatory agencies.

Grup de Malalties Hepàtiques del VHIR

A clinical trial has led to approval of the first drug for advanced fatty liver disease

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

See more

Related professionals

Isaac Manjon Fernández

Isaac Manjon Fernández

Research technician
Microbiome Research
Read more
Carles Bravo Masgoret

Carles Bravo Masgoret

Pneumology
Read more
Natalia Rey Viñets

Natalia Rey Viñets

Research technician
Genetics Medicine
Read more
Juan Duque Yehail

Juan Duque Yehail

Predoctoral researcher
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.